MDM2 and diffuse large B-cell lymphoma: Collectively, we demonstrated that decreased IDO1 activity could activate the p53 pathway by suppressing MDM2 expression and inhibit DLBCL cell growth by inducing the p53 apoptotic pathway and cell cycle arrest.